Pedersen Kim Brint, Geng Chuan-dong, Vedeckis Wayne V
Department of Biochemistry and Molecular Biology and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, 533 Bolivar Street, New Orleans, Louisiana 70112, USA.
Biochemistry. 2004 Aug 31;43(34):10851-8. doi: 10.1021/bi049458u.
Glucocorticoids up-regulate the glucocorticoid receptor (GR) in the human T-lymphoblast cell line CEM-C7. One mechanism for the up-regulation of the GR protein is the well-known up-regulation of GR transcripts. We have investigated the effect of other factors on the up-regulation. At least three promoters (1A, 1B, and 1C) exist, which give rise to GR transcripts with different exon 1 sequences. Transcripts with different exon 1 sequences have similar stabilities. Glucocorticoids have little, if any, effect on mRNA stability. In transfection experiments of the GR-deficient mouse fibroblast cell line E8.2, different exon 1 sequences furthermore caused no significant differences in the translational efficiencies of GR transcripts. However, the ratio between the concentrations of the glucocorticoid receptor B (GR-B) isoform and the glucocorticoid receptor A (GR-A) isoform was higher for transcripts containing the exon 1A3 sequence arising from promoter 1A than in transcripts containing exon 1 sequences from promoters 1B and 1C. Because the GR-B isoform is more active in transactivation then GR-A, this would tend to fine-tune glucocorticoid responsiveness of CEM-C7 cells, which express exon 1A3-containing transcripts. We also found that glucocorticoids do not decrease the stability of the GR protein in CEM-C7 cells. In contrast to other cell lines that downregulate GR expression in response to glucocorticoids, CEM-C7 lymphoblasts possess three mechanisms ensuring high glucocorticoid responsiveness: an up-regulation of GR mRNA by glucocorticoids, no destabilization of GR protein by glucocorticoids, and a high activity of promoter 1A with concomitant high expression of the GR-B isoform.
糖皮质激素可上调人T淋巴母细胞系CEM-C7中的糖皮质激素受体(GR)。GR蛋白上调的一种机制是众所周知的GR转录本上调。我们研究了其他因素对这种上调的影响。至少存在三种启动子(1A、1B和1C),它们产生具有不同外显子1序列的GR转录本。具有不同外显子1序列的转录本具有相似的稳定性。糖皮质激素对mRNA稳定性几乎没有影响(如果有影响的话)。在GR缺陷型小鼠成纤维细胞系E8.2的转染实验中,不同的外显子1序列在GR转录本的翻译效率上也没有引起显著差异。然而,与含有来自启动子1B和1C的外显子1序列的转录本相比,含有由启动子1A产生的外显子1A3序列的转录本中,糖皮质激素受体B(GR-B)异构体与糖皮质激素受体A(GR-A)异构体的浓度比更高。由于GR-B异构体在反式激活中比GR-A更具活性,这将倾向于微调表达含外显子1A3转录本的CEM-C7细胞的糖皮质激素反应性。我们还发现,糖皮质激素不会降低CEM-C7细胞中GR蛋白的稳定性。与其他因糖皮质激素而下调GR表达的细胞系不同,CEM-C7淋巴母细胞具有三种确保高糖皮质激素反应性的机制:糖皮质激素上调GR mRNA、糖皮质激素不会使GR蛋白不稳定以及启动子1A的高活性伴随GR-B异构体的高表达。